# Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

> **NCT04487912** · PHASE4 · WITHDRAWN · sponsor: **University Hospital, Ghent**

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node

## Interventions

- **DRUG:** Tilmanocept
- **DRUG:** Nanocolloid

## Key facts

- **NCT ID:** NCT04487912
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11-24
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient patient inclusion
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04487912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04487912, "Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04487912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*